These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 27705736)
1. MLL translocation in two castration-resistant prostate cancer patients. Chowdry RP; Ledet E; Ranasinghe L; Sartor AO Can J Urol; 2016 Oct; 23(5):8483-8486. PubMed ID: 27705736 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements]. He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048 [TBL] [Abstract][Full Text] [Related]
4. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia]. Zhang LJ; Lu XL; He J; Li Y Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570 [TBL] [Abstract][Full Text] [Related]
5. Targeting epigenetic programs in MLL-rearranged leukemias. Bernt KM; Armstrong SA Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057 [TBL] [Abstract][Full Text] [Related]
6. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma. Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731 [TBL] [Abstract][Full Text] [Related]
7. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Naghashpour M; Lancet J; Moscinski L; Zhang L Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125 [TBL] [Abstract][Full Text] [Related]
8. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia. Chowdhury T; Brady HJ Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612 [TBL] [Abstract][Full Text] [Related]
9. Association of MLL amplification with poor outcome in acute myeloid leukemia. Maitta RW; Cannizzaro LA; Ramesh KH Cancer Genet Cytogenet; 2009 Jul; 192(1):40-3. PubMed ID: 19480936 [TBL] [Abstract][Full Text] [Related]
10. [Detection of rearrangements of mixed lineage leukemia gene and its clinical significance]. Chen WH; Chen CJ; Wang MC; Li CG; You WW; Huang RH; Li M; Tao XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):20-4. PubMed ID: 17490513 [TBL] [Abstract][Full Text] [Related]
11. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Kreuziger LM; Porcher JC; Ketterling RP; Steensma DP Leuk Res; 2007 Aug; 31(8):1145-8. PubMed ID: 17250889 [TBL] [Abstract][Full Text] [Related]
12. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia. Balgobind BV; Zwaan CM; Pieters R; Van den Heuvel-Eibrink MM Leukemia; 2011 Aug; 25(8):1239-48. PubMed ID: 21566656 [TBL] [Abstract][Full Text] [Related]
13. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia. Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060 [TBL] [Abstract][Full Text] [Related]
14. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia. Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736 [TBL] [Abstract][Full Text] [Related]
15. Partial duplication of the MLL oncogene in patients with aggressive acute myeloid leukemia. Sambani C; La Starza R; Roumier C; Crescenzi B; Stavropoulou C; Katsarou O; Karafoulidou A; Dhalle JH; Lai JL; Preudhomme C; Martelli MF; Mecucci C Haematologica; 2004 Apr; 89(4):403-7. PubMed ID: 15075073 [TBL] [Abstract][Full Text] [Related]
16. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia. Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549 [TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer. Josefsson A; Linder A; Flondell Site D; Canesin G; Stiehm A; Anand A; Bjartell A; Damber JE; Welén K Prostate; 2017 Jun; 77(8):849-858. PubMed ID: 28295408 [TBL] [Abstract][Full Text] [Related]
18. Current management of advanced and castration resistant prostate cancer. Gomella LG; Petrylak DP; Shayegan B Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717 [TBL] [Abstract][Full Text] [Related]
19. The Role of PCA 3 as a Prognostic Factor in Patients with Castration-resistant Prostate Cancer (CRPC) Treated with Docetaxel. Bourdoumis A; Chrisofos M; Stasinou T; Christopoulos P; Mourmouris P; Kostakopoulos A; Deliveliotis C Anticancer Res; 2015 May; 35(5):3075-9. PubMed ID: 25964598 [TBL] [Abstract][Full Text] [Related]
20. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Milne TA; Martin ME; Brock HW; Slany RK; Hess JL Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]